IQE PLC

Director's Dealing • May 18, 2023

National Storage Mechanism | Additional information

RNS Number : 8948Z

IQE PLC

18 May 2023

IQE plc

Cardiff, UK

18 May 2023

Director/PDMR Shareholding

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, has been notified that, on 18 May 2023, the following purchases of ordinary shares of 1p each ("Ordinary Shares") were made as part of their participation in IQE's placing, the results of which were announced on 18 May 2023.

Names	Position	No. Ordinary Shares acquired	Resultant holding*	% issued share capital*
Americo Lemos	Chief Executive Officer	7,500,000	8,470,457	0.89%
Dr Andrew W Nelson	President and Non-Executive Director	5,000,000	45,567,234	4.77%
Phil Smith	Chairman	100,000	140,000	0.01%
Carol Chesney	Non-Executive Director	50,000	90,000	0.01%
Victoria Hull	Non-Executive Director	50,000	281,192	0.03%

*as at admission of the 150,000,000 new Ordinary Shares issued as a result of the Placing, expected to take place on or around 22 May 2023.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1.

Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

1.   Mr Americo Lemos

2.   Dr Andrew W Nelson

3.   Phil Smith

4.   Carol Chesney

5.   Victoria Hull

2.

Reason for the notification

a)

Position / status

1.   Chief Executive Officer

2.   President and Non-Executive Director

3.   Chairman

4.   Non-Executive Director

5.   Non-Executive Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQE plc

b)

Legal Entity Identifier

213800Y33WHD3ESJJP16

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 1 pence each in the Company

GB0009619924

b)

Nature of the transaction

Award of shares

c)

Price(s) and volume(s)

	Price	Volume
1.	20.0p	7,500,000
2.	20.0p	5,000,000
3.	20.0p	100,000
4.	20.0p	50,000
5.	20.0p	50,000

d)

Aggregated information

·       Aggregated volume

·       Aggregated price

n/a - single transactions

e)

Date of the transaction(s)

18 May 2023

f)

Place of the transaction

Off-market

Contacts:

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Tim Pullen

Amy Barlow

Peel Hunt LLP (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Paul Gillam

Richard Chambers

James Smith

Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubenstein

Iqra Amin

Headland Consultancy (Financial PR)

+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHNKFBNCBKKOPD